Nuclear Medicine and Biology
Volume 35, Issue 3 , Pages 299-303 , April 2008

Positron emission tomography and target-controlled infusion for precise modulation of brain drug concentration

  • Olof Eriksson

      Affiliations

    • Uppsala Imanet AB, 751 85 Uppsala, Sweden
    • Department of Radiology, Oncology and Clinical Immunology, Division of Radiology, Uppsala University, 751 85 Uppsala, Sweden
    • Corresponding Author InformationCorresponding author. Biology Department, Uppsala Imanet AB, 751 83 Uppsala, Sweden. Tel.: +46 18 666863; fax: +46 18 666879.
    • ,
  • Ray Josephsson

      Affiliations

    • Clinical Imaging Unit, Novartis Pharma AG, CH 9057 Basel, Switzerland
    • ,
  • Bengt Långstrom

      Affiliations

    • Uppsala Imanet AB, 751 85 Uppsala, Sweden
    • ,
  • Mats Bergström

      Affiliations

    • Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, 751 24 Uppsala, Sweden

Received 11 October 2007 ,Revised 7 December 2007 ,Accepted 11 December 2007.

References 

  1. Van Poucke GE, Bravo LJ, Shafer SL. Target controlled infusions: targeting the effect site while limiting peak plasma concentration. IEEE Trans Biomed Eng. 2004;51(11):1869–1875
  2. Guarracino F, Lapolla F, Cariello C, Danella A, Doroni L, Baldassarri R. Target controlled infusion: TCI. Minerva Anestesiol. 2005;71(6):335–337[Review]
  3. Absalom A, Kenny GN. Current and future applications of target-controlled infusions. Drugs Today (Barc). 1999;35(11):823–834
  4. Dyck JB, Maze M, Haack C, Azarnoff DL, Vuorilehto L, Shafer SL. Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology. 1993;78(5):821–828
  5. Fiset P, Paus T, Daloze T, Plourde G, Meuret P, Bonhomme V. Brain mechanisms of propofol-induced loss of consciousness in humans: a positron emission tomographic study. J Neurosci. 1999;19(13):5506–5513
  6. Gustafsson LL, Ebling WF, Osaki E, Harapat S, Stanski DR, Shafer SL. Plasma concentration clamping in the rat using a computer-controlled infusion pump. Pharm Res. 1992;9(6):800–807
  7. Hacker SO, White CE, Black IH. A comparison of target-controlled infusion versus volatile inhalant anesthesia for heart rate, respiratory rate, and recovery time in a rat model. Contemp Top Lab Anim Sci. 2005;44(5):7–12
  8. Yamakage M, Iwasaki S, Jeong SW, Ishiyama SI, Namiki A. Comparative study between propofol in a long-chain triglyceride and propofol in a medium/long-chain triglyceride during sedation with target-controlled infusion. Anaesth Intensive Care. 2005;33(3):351–355
  9. Breslin DS, Mirakhur RK, Reid JE, Kyle A. Manual versus target-controlled infusions of propofol. Anaesthesia. 2004;59(11):1059–1063
  10. Russell D, Wilkes MP, Hunter SC, Glen JB, Hutton P, Kenny GN. Manual compared with target-controlled infusion of propofol. Br J Anaesth. 1995;75(5):562–566
  11. Kucken AM, Teissere JA, Seffinga-Clark J, Wagner DA, Czajkowski C. Structural requirements for imidazobenzodiazepine binding to GABA(A) receptors. Mol Pharmacol. 2003;63(2):289–296
  12. Haefely W, Hunkeler W. The story of flumazenil. Eur J Anaesthesiol Suppl. 1988;2:3–13
  13. Bergström M, Långström B. Pharmacokinetic studies with PET. In:  Rudin M editors. Progress in drug research. vol. 62:Birkhäuser Verlag: Basel; 2005;p. 281–317
  14. Wall A, Kågedal M, Bergstrom M, Jacobsson E, Nilsson D, Antoni G. Distribution of zolmitriptan into the CNS in healthy volunteers: a positron emission tomography study. Drugs R&D. 2005;6(3):139–147
  15. Carson RE, Channing MA, Blasberg RG, Dunn BB, Cohen RM, Rice KC. Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab. 1993;13:24–42
  16. Carson RE, Breier A, de Bartolomeis A, Saunders RC, Su TP, Schmall B. Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. J Cereb Blood Flow Metab. 1997;17:437–447
  17. Carson RE. PET physiological measurements using constant infusion. Nucl Med Biol. 2000;27:657–660
  18. Koeppe RA, Frey KA, Kume A, Albin R, Kilbourn MR, Kuhl DE. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography. J Cereb Blood Flow Metab. 1997;17(9):919–931
  19. Samson Y, Hantraye P, Baron JC, Soussaline F, Comar D, Maziere M. Kinetics and displacement of Ro-15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron emission tomography. Eur Pharmacol. 1985;110:247–251
  20. Alkire MT, Haier RJ. Correlating in vivo anaesthetic effects with ex vivo receptor density data supports a GABAergic mechanism of action for propofol, but not for isoflurane. Br J Anaesth. 2001;86(5):618–626
  21. Liao M, Sonner JM, Jurd R, Rudolph U, Borghese CM, Harris RA. Beta3-containing gamma-aminobutyric acidA receptors are not major targets for the amnesic and immobilizing actions of isoflurane. Anesth Analg. 2005;101(2):412–418
  22. Zhang Y, Sonner JM, Eger EI, Stabernack CR, Laster MJ, Raines DE. Gamma-aminobutyric acidA receptors do not mediate the immobility produced by isoflurane. Anesth Analg. 2004;99(1):85–90
  23. Hentschke H, Schwarz C, Antkowiak B. Neocortex is the major target of sedative concentrations of volatile anaesthetics: strong depression of firing rates and increase of GABAA receptor-mediated inhibition. Eur J Neurosci. 2005;21(1):93–102
  24. Jenkins A, Greenblatt EP, Faulkner HJ, Bertaccini E, Light A, Lin A. Evidence for a common binding cavity for three general anesthetics within the GABAA receptor. J Neurosci. 2001;21(6):RC136
  25. Syvänen S, Blomqvist G, Sprycha M, Höglund U, Roman M, Eriksson O. Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood–brain barrier can be studied with PET. Neuroimage. 2006;32:1134–1141
  26. Hantraye P, Brouillet E, Fukuda H, Chavoix C, Guibert B, Dodd RH. Benzodiazepine receptors studied in living primates by positron emission tomography: antagonist interactions. Eur J Pharmacol. 1988;153:25–32

PII: S0969-8051(07)00307-1

doi: 10.1016/j.nucmedbio.2007.12.003

Nuclear Medicine and Biology
Volume 35, Issue 3 , Pages 299-303 , April 2008

Article Tools

* Image Usage & Resolution